Literature DB >> 17462975

A revision on cryoglobulinaemia associated to neoplastic diseases.

M J Molina-Garrido1, C Guillén-Ponce.   

Abstract

Cryoglobulinaemia is an infrequent process and has been classified in types I, II and III. Type I corresponds to monoclonal cryoglobulinaemia; types II and III are comprised in the group of mixed cryoglobulinaemias (MC). In MC type II, cryoglobulinaemias are made up of a monoclonal rheumatoid factor vs. a polyclonal IgG. In MC type III all compounds are polyclonal. Monoclonal cryoglobulinaemias are usually associated to malignant haematological processes, while MC are associated to systemic diseases and infection. More research is needed on the natural history, causes, treatment and evolution of cryoglobulinaemia. This revision analyses a more recent knowledge on this entity, as well as its association to neoplastic diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462975     DOI: 10.1007/s12094-007-0044-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  4 in total

1.  A case of MPO- and PR3-ANCA-negative pauci-immune renal-limited small-vessel vasculitis associated with endometrial neuroendocrine small cell carcinoma.

Authors:  Shuzo Kaneko; Yusuke Tsukamoto; Kazuya Abe; Masayuki Yonamine; Sumiko Hasegawa; Hiromi Hikida
Journal:  CEN Case Rep       Date:  2013-01-26

Review 2.  Does my patient with a serum monoclonal spike have multiple myeloma?

Authors:  Giada Bianchi; Irene M Ghobrial
Journal:  Hematol Oncol Clin North Am       Date:  2012-04       Impact factor: 3.722

3.  Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").

Authors:  Eric A Engels; Ruth Parsons; Caroline Besson; Lindsay M Morton; Lindsey Enewold; Winnie Ricker; Elizabeth L Yanik; Hannah Arem; April A Austin; Ruth M Pfeiffer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-26       Impact factor: 4.254

4.  Cryoglobulinemic membranoproliferative glomerulonephritis associated with mucosa-associated lymphoid tissue lymphoma treated with rituximab.

Authors:  Austin Y Ha; Nicole Noronha; Patrick Gleason; Jonathan N Winkler; James N Butera; Kammi J Henriksen; Susie L Hu
Journal:  Clin Nephrol Case Stud       Date:  2016-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.